Publicaciones en colaboración con investigadores/as de Centro de Investigación Príncipe Felipe (7)

2020

  1. Dapagliflozin does not modulate atherosclerosis in mice with insulin resistance

    International Journal of Molecular Sciences, Vol. 21, Núm. 23, pp. 1-18

2019

  1. Changes in CDKN2A/2B expression associate with T-cell phenotype modulation in atherosclerosis and type 2 diabetes mellitus

    Translational Research, Vol. 203, pp. 31-48

  2. Type 1 diabetic mellitus patients with increased atherosclerosis risk display decreased CDKN2A/2B/2BAS gene expression in leukocytes

    Journal of Translational Medicine, Vol. 17, Núm. 1

2016

  1. Hepatic lipase inactivation decreases atherosclerosis in insulin resistance by reducing LIGHT/lymphotoxin β-receptor pathway

    Thrombosis and Haemostasis, Vol. 116, Núm. 2, pp. 379-393

2015

  1. Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis

    Journal of Endocrinology, Vol. 227, Núm. 3, pp. 179-191

2014

  1. Insulin resistance aggravates atherosclerosis by reducing vascular smoothmuscle cell survival and increasing CX3CL1/CX3CR1 axis

    Cardiovascular Research, Vol. 103, Núm. 2, pp. 324-336

2011

  1. Reduced penetrance of autosomal dominant hypercholesterolemia in a high percentage of families: Importance of genetic testing in the entire family

    Atherosclerosis, Vol. 218, Núm. 2, pp. 423-430